category: Markets
-
Nvidia’s Jensen Huang Says AI Could Spark 4 Day Work Weeks—B…
[ad_1] Nvidia Corp. NVDA CEO Jensen Huang believes artificial intelligence could trigger a shift to four-day work weeks, but cautioned that workers will paradoxically become busier than ever as artificial intelligence accelerates business execution and idea generation. Check out the current price of NVDA stock here. AI Revolution Promises Shorter Weeks, Intensified Pace Speaking on…
-
Bill Ackman Blames ‘Forced Selling’ By Leveraged Traders For…
[ad_1] Billionaire investor Bill Ackman has attributed the recent dramatic volatility across rates, currencies, and equities to “forced selling” by highly leveraged market participants, rather than fundamental economic shifts. What Happened: In an X post, Ackman argued that investors and market commentators are overinterpreting short-term market movements, mistaking technical liquidations for signals of underlying economic…
-
Elon Musk’s Tesla At Risk Of Being Removed From EV Incentive…
[ad_1] In a bid to protect its automotive industry, the United Kingdom is actively negotiating with Washington to secure an exemption from impending U.S. auto tariffs. The 25% tariffs, announced by U.S. President Donald Trump, are scheduled to come into effect on April 3. What Happened: Finance Minister Rachel Reeves has underscored the critical nature…
-
Top 2 Energy Stocks That May Collapse In Q1 – KNOT Offshore …
[ad_1] As of March 21, 2025, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices…
-
Asia Markets Mixed, Europe Slips As China’s Tariff Retaliati…
[ad_1] On Tuesday, February 4, U.S. markets closed higher, driven by energy sector gains, as optimism grew over a potential U.S.-China trade breakthrough. Trump delayed Mexico-Canada tariffs but imposed new levies on China, prompting retaliation. Strong corporate earnings lifted sentiment, with Palantir surging 24%. Fed officials warned of inflation risks from tariffs, while job openings…
-
Google Parent-Owned Startup To Launch AI-Designed Drug Trial…
[ad_1] A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as major tech companies increasingly invest in AI-powered healthcare solutions. What Happened: Isomorphic Labs, an Alphabet Inc. GOOGL subsidiary, is targeting major disease areas including oncology, cardiovascular conditions, and…